Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Niacin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 6Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    NA to NAM ratio as a biomarker for cell therapy sterility
    NA to NAM ratio as a biomarker for cell therapy sterility

    20 Jul 2022

    // Hannah Balfour EUROPEANPHARMACEUTICALREVIEW

    https://www.europeanpharmaceuticalreview.com/news/173186/na-to-nam-ratio-as-a-biomarker-for-cell-therapy-sterility/

    Hannah Balfour EUROPEANPHARMACEUTICALREVIEW
    20 Jul 2022
    Share Share
    Macleod Pharms' Generic Niacin Receives Approval in the U.S.
    Macleod Pharms' Generic Niacin Receives Approval in the U.S.

    03 Mar 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204934

    FDA
    03 Mar 2022
    Share Share
    With Vascepa nod in the bag, Amarin rolls CV risk campaign
    With Vascepa nod in the bag, Amarin rolls CV risk campaign

    23 Jan 2020

    // B. S Bulik FIERCE PHARMA

    https://www.fiercepharma.com/marketing/amarin-launches-cv-risks-awareness-campaign-cautions-outdated-drugs-and-non-fda

    B. S Bulik FIERCE PHARMA
    23 Jan 2020
    Share Share
    Yichang Humanwell's Generic Niacin Receives Approval in US
    Yichang Humanwell's Generic Niacin Receives Approval in US

    10 Jun 2019

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212017

    FDA
    10 Jun 2019
    Share Share
    Health Canada Issues Type II Drug Recall of Genestra Brands AFA-Gen
    Health Canada Issues Type II Drug Recall of Genestra Brands AFA-Gen

    17 Aug 2018

    // HEALTH CANADA

    http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2018/67530r-eng.php

    HEALTH CANADA
    17 Aug 2018
    Share Share
    Jubilant Generics Niacin Receives Approval In US
    Jubilant Generics Niacin Receives Approval In US

    16 May 2018

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209156

    FDA
    16 May 2018
    Share Share